sTREM-1 is a potential useful biomarker for exclusion of ongoing infection in patients with secondary peritonitis

Cytokine

Volumn 46, Issue 1, 2009, Pages 36-42

  Determann, Rogier M ^a   Olivier van Till, J W ^a   van Ruler, Oddeke ^a   van Veen, Suzanne Q ^a   Schultz, Marcus J ^a   Boermeester, Marja A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Abdominal sepsis; Biological marker; Sensitivity and specificity; sTREM 1

Indexed keywords

MEMBRANE PROTEIN; PROTEIN STREM1; UNCLASSIFIED DRUG;

ABDOMINAL INFECTION; ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LAPAROTOMY; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PERITONITIS; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE;

AGED; BIOLOGICAL MARKERS; ENDOSCOPY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PERITONITIS; PREDICTIVE VALUE OF TESTS; RECEPTORS, IMMUNOLOGIC; RETROSPECTIVE STUDIES; SEPSIS; TREATMENT OUTCOME;

EID: 62749124794     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.12.006     Document Type: Article

References (26)

1. Schein M. Management of severe intra-abdominal infection. Surg Annu 24 (1992) 47-68
2. Lamme B., Boermeester M.A., Belt E.J., van Till J.W., Gouma D.J., and Obertop H. Mortality and morbidity of planned relaparotomy versus relaparotomy on demand for secondary peritonitis. Br J Surg 91 (2004) 1046-1054
3. Solomkin J.S., Dellinger E.P., Christou N.V., and Busuttil R.W. Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections. Ann Surg 212 (1990) 581-591
4. Condon R.E., Walker A.P., Sirinek K.R., White P.W., Fabian T.C., Nichols R.L., et al. Meropenem versus tobramycin plus clindamycin for treatment of intraabdominal infections: results of a prospective, randomized, double-blind clinical trial. Clin Infect Dis 21 (1995) 544-550
5. Dougherty S.H., Sirinek K.R., Schauer P.R., Fink M.P., Fabian T.C., Martin D.H., et al. Ticarcillin/clavulanate compared with clindamycin/gentamicin (with or without ampicillin) for the treatment of intra-abdominal infections in pediatric and adult patients. Am Surg 61 (1995) 297-303
6. Solomkin J.S., Reinhart H.H., Dellinger E.P., Bohnen J.M., Rotstein O.D., Vogel S.B., et al. Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections. The Intra-Abdominal Infection Study Group. Ann Surg 223 (1996) 303-315
7. Bosscha K., van Vroonhoven T.J., and van der W.C. Surgical management of severe secondary peritonitis. Br J Surg 86 (1999) 1371-1377
8. Holzheimer R.G., Schein M., and Wittmann D.H. Inflammatory response in peritoneal exudate and plasma of patients undergoing planned relaparotomy for severe secondary peritonitis. Arch Surg 130 (1995) 1314-1319
9. Frohlich D., Eiber R.M., Jochum M., and Billing A. Perioperative pattern of peritoneal interleukin 8, tumour necrosis factor-alpha, and granulocyte elastase release in human secondary peritonitis. Cytokine 9 (1997) 288-292
10. Scheingraber S., Bauerfeind F., Bohme J., and Dralle H. Limits of peritoneal cytokine measurements during abdominal lavage treatment for intraabdominal sepsis. Am J Surg 181 (2001) 301-308
11. Zugel N., Siebeck M., Geissler B., Lichtwark-Aschoff M., Gippner-Steppert C., Witte J., et al. Circulating mediators and organ function in patients undergoing planned relaparotomy vs. conventional surgical therapy in severe secondary peritonitis. Arch Surg 137 (2002) 590-599
12. Herwig R., Glodny B., Kuhle C., Schluter B., Brinkmann O.A., Strasser H., et al. Early identification of peritonitis by peritoneal cytokine measurement. Dis Colon Rectum 45 (2002) 514-521
13. Bouchon A., Dietrich J., and Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 164 (2000) 4991-4995
14. Bleharski J.R., Kiessler V., Buonsanti C., Sieling P.A., Stenger S., Colonna M., et al. A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response. J Immunol 170 (2003) 3812-3818
15. Knapp S., Gibot S., de Vos A., Versteeg H.H., Colonna M., and van der Poll T. Cutting edge: expression patterns of surface and soluble triggering receptor expressed on myeloid cells-1 in human endotoxemia. J Immunol 173 (2004) 7131-7134
16. Gibot S., Kolopp-Sarda M.N., Bene M.C., Cravoisy A., Levy B., Faure G.C., et al. Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis. Ann Intern Med 141 (2004) 9-15
17. Gibot S., Cravoisy A., Levy B., Bene M.C., Faure G., and Bollaert P.E. Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med 350 (2004) 451-458
18. Determann R.M., Millo J.L., Gibot S., Korevaar J.C., Vroom M.B., van der Poll T., et al. Serial changes in soluble triggering receptor expressed on myeloid cells in the lung during development of ventilator-associated pneumonia. Intensive Care Med 31 (2005) 1495-1500
19. Determann R.M., Weisfelt M., de Gans J., van der Ende A., Schultz M.J., and van de Beek D. Soluble triggering receptor expressed on myeloid cells 1: a biomarker for bacterial meningitis. Intensive Care Med 32 (2006) 1243-1247
20. van Till J.W., Levi M., Bresser P., Schultz M.J., Gouma D.J., and Boermeester M.A. Early procoagulant shift in the bronchoalveolar compartment of patients with secondary peritonitis. J Infect Dis 194 (2006) 1331-1339
21. Capuzzo M., Valpondi V., Sgarbi A., Bortolazzi S., Pavoni V., Gilli G., et al. Validation of severity scoring systems SAPS II and APACHE II in a single-center population. Intensive Care Med 26 (2000) 1779-1785
22. Billing A., Frohlich D., and Schildberg F.W. Prediction of outcome using the Mannheim peritonitis index in 2003 patients. Peritonitis Study Group. Br J Surg 81 (1994) 209-213
23. Deeks J.J., and Altman D.G. Diagnostic tests 4: likelihood ratios. BMJ 329 (2004) 168-169
24. Edmiston C.E., Goheen M.P., Kornhall S., Jones F.E., and Condon R.E. Fecal peritonitis: microbial adherence to serosal mesothelium and resistance to peritoneal lavage. World J Surg 14 (1990) 176-183
25. Van Ruler O., Lamme B., Gouma D.J., Reitsma J.B., and Boermeester M.A. Variables associated with positive findings at relaparotomy in patients with secondary peritonitis. Crit Care Med 35 (2007) 468-476
26. Laroche M., and Harding G. Primary and secondary peritonitis: an update. Eur J Clin Microbiol Infect Dis 17 (1998) 542-550